Abstract
Introduction
Angiogenesis, the generation of new blood vessels, is thought to be necessary for tumor growth and metastasis [18] - [20] . This process belongs to a general family of tumor-immune interactions. Some recent studies, including mathematical models of angiogenesis dynamics, are presented in [2] , [11] , [13] , [15] - [20] , [23] - [24] , [29] , [31] and [32] . To incorporate the spatial effects of the diffusion factors that stimulate and inhibit angiogenesis, the following two-compartmental model for cancer cells and vascular endothelial cells was developed by P. Hahnfeldt in [23] (see, also [31] ). dx dt = αx(t) ln K(t) x(t) dK dt = −µK(t) + S(x(t), K(t)) − I(x(t), K(t)) − c(t)K(t),
where x(t) is the tumor mass and K(t) is a variable carrying capacity, that is defined as the effective vascular support provided to the tumor as reflected by the size of the tumor potentially sustainable by it. According to P. Hahnfeldt, a stimulator/inhibitor tumor growth dynamics, described by system (1), should provide a time dependent carrying capacity under angiogenic control and include the distinct mechanisms for angiogenic stimulation and inhibition. The dynamics of the second equation is a balance between stimulatory and inhibitory effects: first term is the loss of functional vasculature; the second term corresponds the stimulatory capacity of the tumor. The third term reflects endogenous inhibition by either neutralizing endothelial cell growth factors or inhibition endothelial cell proliferation. These inhibitors are released through the tumor surface (scaling the tumor volume to its surface area); thus the major assumption for the Hahnfeldt models is
where θ + µ = 2/3.
The last term in model (1) represents inhibition of tumor vasculature due to administered therapy. The following pharmokinetic differential equation
might be used to model chemo-or radio-therapy mechanisms. Here v(t) is a dose given and q is a per capita decay rate of the drug once it is injected. If we assume that the drug kills all types of cells [24] , then
To model processes in nature it is frequently required to know system states from the past, i.e., models incorporating memory. Depending on the phenomena under study the after-effects represent duration of some hidden processes, for example, time lags of transit through one state to another; transit time through compartments, or time lags associated with the growth rates (cell division/differentiation time). In any cell growth some cells are inactive and, once activated, the cell division is not instantaneous. There are delays in cell division. For example, cells can be engaged in an active cell cycle and might divide with a fairly regular periodicity. On the other hand, cells can be in a resting state (i.e., having dropped out of the cell cycle because of lack of positive growth signals) and will experience a delay in resuming the cell cycle at the same place that they left. In human cells this delay is usually about 8 hours. One might imagine that in addition to carrying oxygen and nutrients to tumor cells in a tumor mass, vascularization may also deliver growth hormones (signals) that would stimulate otherwise quiescent cells to reenter the cell division cycle and thereby contribute to an increase in tumor mass. The Warburg effect on angiogenesis and metastasis is a different mechanism with the after-effects (see, for example, [27] ). Essentially cancer cells continue to use glycolysis much more than regular cells, even when there is plenty of oxygen around. This produces an acidic environment (by the production of lactic acid from glycolysis) which in turn stimulates angiogenesis. Presumably there is a lag time required to bring the tumor environment to the optimal pH for endothelial cell growth. In terms of inhibition, there could be time lags between cells receiving an inhibitory signal and actually dropping out of the cell cycle. Usually cells will continue through their cycle after receiving a signal and all stop at the same spot on the cycle (called a restriction point). The inclusion of explicit time lags in the model allows direct reference to experimentally measurable and/or controllable cell growth characteristics (e.g., time required to perform the necessary divisions). In general, models with delays produce a complex and nontrivial dynamics: it switches stable trajectories into unstable cycles or periodic oscillations. In cancer therapy, stability switching is a very important issue in the design of a drug protocol (see, for example, [1] , [3] , [14] and [33] ).
If we assume that the tumor cells enter the mechanisms of angiogenic stimulation and inhibition with some delays h(t) ≤ t, then model (1) has two alternative forms:
Model 2.
Note that a logistic-type model with Richards nonlinearity
could also be used for modelling tumor growth dynamics [23] . Here m > 0 and m = 1 is a constant that drops an unnatural symmetry of the classical logistic curve (m = 1).
Note that all models without time lags were studied in [13] , [15] , [23] and [31] .
Systems (3)- (5) belong to a wide class of the delay differential equations
where x ∈ R n , A ∈ R n×n and F : R + × R n × R n → R n is a nonlinear and continuous vector function. Stability analysis of the delay differential equation (6) is a well-trodden area, however, some existing results rely on restrictive conditions, e.g., strict monotonicity and boundedness of the functions and operators involved, continuity of the parameters [5] , [12] , [21] , [22] , [26] , [28] and [30] . For example, models under study possess non-Lipchitz nonlinearity, thus stability analysis for models (3)-(5) requires new tools and approaches. Moreover, since the models in the paper are based on nonautonomous equations, the application of the traditional methods for autonomous equations, such as Laplace transforms or quasipolynomials, is questionable.
The purpose of this paper is two-fold: obtain new results in the qualitative theory of delay differential equations; apply the results to the analysis of the models of angiogenesis dynamics. Firstly, for some general class of nonlinear nonautonomous systems with delays we obtained conditions for the existence of a global attractor; and based on that result, we proved local stability for Model l. Compared with Model 1, Model 2 has different qualitative features, thus for its analysis, we used the theorems recently obtained for a Lienardtype second-order differential equation with delays [4] . In the Discussion we pose some open problems.
Global Stability Criteria
We will begin by examining the global stability of a general class of the following nonlinear nonautonomous systems with delays.
where |f i,j (t, u)| ≤ b ij (t)|u|, a ij (t) and b ij (t) are measurable essentially bounded functions, f ij (t, ·) is a continuous function, f ij (·, u) is a measurable locally essentially bounded function and h ij (t) ≤ t are measurable functions. Along with equations (7) we set the initial condition for each t 0 ≥ 0
where ϕ i is a continuous function. A solution X(t) = {x 1 (t), . . . , x n (t)} T of problem (7)- (8) is a vector function, locally absolutely continuous for t ≥ t 0 , that satisfies almost everywhere equation (7) on this interval and initial condition (8) for t ≤ t 0 . A unique global solution of problem (7)- (8) Let A ij = sup t≥t 0 |a ij (t)| and B ij = sup t≥t 0 |b ij (t)|.
Theorem 2.1 Suppose there exist
T of equation (7) lim t→∞ X(t) = 0.
Proof. After substitution x i (t) = e −λ(t−t 0 ) y i (t), t ≥ t 0 , where 0 < λ < min i a i , system (7) has a forṁ
Hence
Then
We define the matrix C(λ) = {c ij (λ)} with entries
We have lim λ→0 C(λ) = C(0). Since matrix B is an M-matrix, then C(0) is also an M-matrix; thus the main minors of C(0) are positive. If for some values of parameters the elements of a matrix are continuous functions then the determinant of this matrix is a continuous function. For some λ > 0 all main minors of C(λ) are positive, the latter implies that this matrix is an M-matrix. Assume that parameter is fixed λ = λ 0 . Thus for Y b there is an a priory estimate Y b ≤ C −1 (λ 0 )|X(t 0 )| where the right-hand side does not depend on b; therefore Y (t) is a bounded function. Finally, X(t) = e −λ(t−t 0 ) Y (t), then lim t→∞ X(t) = 0. The theorem is proven.
Existence of Global Solutions
In what follows, we assume 0 ≤ t−h(t) ≤ τ , x(t) = φ(t) f or t < t 0 x(t 0 ) = x 0 and K(t 0 ) = K 0 , where p(t) and c(t) are measurable essentially bounded functions, h(t) is a measurable function and φ is a continuous function.
Definition 3.1 Any solution of problems (3)-(5) is a locally absolutely continuous function if it satisfies the equation almost everywhere for t > t 0 and the initial conditions for
Proof. Without loss of generality, we prove the theorem for system (3). The proof for models 2 and 3 is similar. Suppose for simplicity that t 0 = 0. Consider the second equation in system (3) for t ∈ [0, τ 0 ]. This linear equation has a formK (t) = a(t)
Hence K(t) > 0 for t ∈ [0, τ 0 ]. Consider the first equation in system (3) for t ∈ [0, τ 0 ]. This is a nonlinear ordinary differential equation for the function x(t) with a known positive function K(t). Since x(0) > 0, then there exists a local solution of this equation. On the interval of the existence of this solution we have
hence on this interval the solution is positive. Suppose that the maximum interval of the existence of the solution of this equation is [0, t 0 ) for t 0 < τ 0 . Since x(t) > 0 then lim t→t 0 x(t) = +∞. Therefore there exists 0 < t 1 < t 0 such that
We have ln (4) and (5). In view of Theorem 3.1 we assume that there exists 0 < τ 1 < τ 0 such that
Models with Constant Rate of Infusion
Standard chemo-and radio-therapies are typically administered in a constant dose scheduling, i.e., c(t) = c 0 and p(t) = p 0 .
Stability Analysis for Model 1
Then system αx ln
has a unique positive equilibrium point
where η = βe
Let introduce new variables u(t) = ln x x * and v(t) = ln K K * , then system (9) has the following exponential form with the trivial equilibrium
At (0, 0) a linearization of system (12) has the following form Proof. To apply Theorem 2.1 we set a matrix
Clearly,
Hence B −1 is an M-matrix, provided that inequality (11) holds. By Theorem 2.1 system (12) is exponentially stable; thus system (9) is locally asymptotically stable.
Stability Analysis for Model 2
The system αx ln
provided that β > γ + c 0 . Set u = ln x x * and v = ln K K * , then system (13) has the following form with the trivial equilibrium
).
Nonlinear system (15) is equivalent to a second order delay differential equation
or, if h(t) ≡ t , a second order nonlinear ordinary differential equation
where A = α(β − γ − c 0 ). Equations (16)- (17) belong to a well-known class of a Lienard-type differential equations [6] - [10] .
The following result was obtained by T. Burton [10] . For equation (17) we have f (u) = α > 0, g(u) = A(e 2u(t)/3 − 1), provided A > 0 and u(t) > 0 for all t ≥ 0; thus based on Theorem 4.2, system (17) 
Lemma 4.1 Suppose a(t) ≥ a 0 > 0, t − h(t) ≤ τ , and
Then equation (20) is exponentially stable.
Theorem 4.3 Suppose
Then the positive equilibrium of system (13) is locally exponentially stable.
Proof. Stability of the positive equilibrium of system (13) is equivalent to stability of the trivial solution of equation (16) . Linearized equation for (16) has the form (20) , where a(t) = α and b(t) = 
We quote the following lemma [25] .
Lemma 5.1 Consider the vector equatioṅ
where A k (t) and F (t) are locally essentially bounded matrix and vector func-
is exponentially stable, and lim t→∞ F (t) = 0, then for any solution X of equation (23) Firstly, consider system (3) in the form
(24) After substitution u = ln
where x * and K * are defined by (10) . Linearization for system (25) yields
Lemma 5.1 implies the following result. 
Similar calculations yield
Theorem 5.2 Suppose conditions (21) and (22) hold. Then the pair of numbers (x * , K * ), defined by (14) , is a local attractor for the solutions of system (4). 
Discussion and Open Problems
Mathematical modeling and simulation can potentially provide insight into the underlying causes of tumor invasion and metastasis, help understand clinical observations, and be of use in designing targeted experiments and assessing treatment strategies [1] , [2] and [16] . Compare to some models in literature, where delays were introduced without biological motivation, we give a solid justification for the introduction of the delays into the models. All models are perturbed either by a constant therapy or by time-varying treatments. The existence of unique global solutions for models (3)-(5) follows from Theorem 3.1. For some general class of nonlinear nonautonomous systems with delays we obtained conditions for the existence of a global attractor (Theorem 2.1). Based on Theorem 2.1, we proved local stability for Model l. For local stability analysis of Model 2 we used recent result for a Lienard-type second-order differential equation with delays. Criteria obtained for local attractivity, are explicit and hence are convenient to apply/verify in practice. Note that in Theorems 5.1-5.2 the study of nonautonomous equations is reduced to the study of "limit equations" or asymptotically autonomous systems. Note that the analysis of Model 3 could be achieved by using similar techniques. Finally, we formulate some open problems.
1. Conjecture Model 1 has a global attractor, provided that a positive equilibrium exists.
2.
Conjecture Model 2 has a global attractor, provided that conditions of the Theorem 4.2 are satisfied.
3. Some additional problems which were not included in the paper: lower and upper estimations of the solutions, extinction, existence and asymptotic stability of periodic solutions, oscillation and nonoscillation of the solutions about its positive equilibria.
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